Steve Horwits has spent the last 60 years of his life inspiring generations of Jewish families in Lafayette Hill, Pennsylvania.
Steve Horwits has spent the last 60 years of his life inspiring generations of Jewish families in Lafayette Hill, Pennsylvania.
The "Nasopharyngeal Cancer - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering.
Tesla chief Elon Musk said he is concerned about the increasing use of fossil fuels for bitcoin mining.
The BBC profiles Xi Jinping, president of China and leader of the ruling Communist Party.
The "Spinal Muscular Atrophy - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Nebulizers Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's offering. The global nebulizers market is expected to decline from $1.67 billion in 2020 to $1.04 billion in 2021 at a compound annual growth rate (CAGR) of -37.7%. Nebulizers Global Market Report 2021: COVID-19 Implications and Growth to 2030 covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for nebulizers which play a critical role in the treatment of patients with COVID-19. Major players in the nebulizer devices market are Agilent Technologies, Becton Dickinson and Company, Koninklijke Philips N.V., Omron Corporation, Covidien plc, GE Healthcare Ltd., Allied Healthcare Products, Inc, Briggs Healthcare, PARI Pharma, and GF Health Products, Inc. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $1.55 billion in 2025 at a CAGR of 10.5%.The nebulizer devices market consists of sales of nebulizers used in respiratory care for patients with respiratory diseases including asthma, cystic fibrosis and COPD. The sales consist of revenues generated by establishments that are primarily engaged in the manufacturing of breath actuated and vented pneumatic nebulizers, portable and standalone ultrasonic nebulizers, and static and vibrating type mesh nebulizers.The current Covid-19 pandemic has resulted in a surge in demand for nebulizers. There has been an increased use of albuterol inhalers in hospitals for Covid-19 and suspected Covid-19 patients to help with respiratory issues. This is mainly because respiratory viruses are the most common trigger for asthma exacerbations.Nebulizer therapy requires a device that repeatedly and quickly delivers sufficient drug with minimal wastage, to the site of action. However, during nebulization aerosol with a smaller particle size are inhaled or delivered to the site of action while large particles return to reservoir feeding tube. Also, some of the drug aerosols settle on the walls of the baffle. This drug is retained within the nebulizer, (also called as residual drug or dead volume) or released into environment during expiration. This results in drug wastage. Drug wastage during exhalation is therefore challenging the growth of nebulizer market. The development of technically advanced novel nebulizers is however expected to reduce drug wastage and improve delivery efficacy.The technologically advanced nebulizers including breath-enhanced, breath-actuated, and vibrating mesh nebulizers decrease the amount of drug lost during exhalation while increasing the efficiency of drug delivery and shaping the nebulizer devices market. For example, in June 2020, Respira Technologies, a health technology platform development company, revealed the introduction of a pharmaceutical-focused commercial development programme for its RespiRx drug delivery system. Respirx is a compact, hand-holding vibrating mesh nebulizer built for local and systemic treatment and can work in any position placed by the patient. The latest and advanced nebulizers increase the output rate which in turn will decrease the administration time.Rising geriatric population across the globe is expected to increase the usage of respiratory care devices including nebulizers over the forecast period. For instance, according to the World Health Organization (WHO), by 2050, the world's population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015. As of 2019, 143 million people are aged 80 years or older. According to the United Nations, in 2020, the global population of person aged 65 years and older was estimated to be 727 million and this number is projected to nearly double to over 1.5 billion in 2050. Rise in geriatric population is anticipated to propel the nebulizer market growth.Key Topics Covered: 1. Executive Summary2. Nebulizers Market Characteristics3. Nebulizers Market Trends And Strategies4. Impact Of COVID-19 On Nebulizers5. Nebulizers Market Size And Growth5.1. Global Nebulizers Historic Market, 2015-2020, $ Billion5.1.1. Drivers Of The Market5.1.2. Restraints On The Market5.2. Global Nebulizers Forecast Market, 2020-2025F, 2030F, $ Billion5.2.1. Drivers Of The Market5.2.2. Restraints On the Market6. Nebulizers Market Segmentation6.1. Global Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Pneumatic NebulizerUltrasonic NebulizerMesh Nebulizer 6.2. Global Nebulizers Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion COPDCystic FibrosisAsthmaOthers 6.3. Global Nebulizers Market, Segmentation By End Use, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Hospitals and ClinicsEmergency CentersHome Healthcare 6.4. Global Nebulizers Market, Segmentation By Portability, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Portable NebulizerTabletop Nebulizer 7. Nebulizers Market Regional And Country Analysis7.1. Global Nebulizers Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion7.2. Global Nebulizers Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion8. Asia-Pacific Nebulizers Market8.1. Asia-Pacific Nebulizers Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Nebulizers Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion Companies Mentioned Agilent TechnologiesBecton Dickinson and CompanyKoninklijke Philips N.V.Omron CorporationCovidien plcGE Healthcare Ltd.Allied Healthcare Products, IncBriggs HealthcarePARI PharmaGF Health Products, Inc.Medline Industries Inc.Invacare Corporation For more information about this report visit https://www.researchandmarkets.com/r/tdesc CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
India has fully vaccinated only 3% of its people, but vaccine breakthrough cases appear to be rising.
May 13—An ethics complaint filed this week questions whether one city councilor can occupy his post on Muskogee's nine-member governing board due to alleged business interests. A complaint filed Monday alleges Ward II Councilor Alex Reynolds is ineligible to serve as a municipal officer because of his ownership interests in a medical cannabis business. Reynolds was identified as a director of ...
The British government on Thursday said the English Premier League has been permitted to roll over its present lucrative domestic television deal with broadcasters because of the impact of the coronavirus pandemic.
May 13—Tulsa actress Clare Holt said she knew what she wanted to be after seeing the musical production "Bonnie & Clyde." "After watching it for the first time, I was like, 'oh my gosh, I want to be Bonnie so bad,'" she said. "It's such a good role, especially with her character arc being meek and mousy to being this gangster sort of lady." Holt gets to play the gun-toting Depression era ...
May 13—The turn for home is here. After an unprecedented season of dodging pandemic regulations, with some games falling as casualties to it but not seasons, we reach the final weekend of high school competition this weekend. It all starts Thursday with the state baseball tournaments. Oktaha (30-10) takes on Calera (32-5) at 1 p.m. Thursday in the Class 2A tournament. The game is set for ...
May 13—Cruis'n Angels Car Club will offer a dry covered place to show off and look at cars Saturday at the 23rd annual Car Show. The show will begin 8 a.m. Saturday at the Hatbox Event Center. The show is free to the public. Registration for entries is $20 and runs from 8 a.m. to noon. Going indoors protects the cars and spectators from questionable weather, said Club President Gary Thomson. ...
Amazon has signed a multi-year deal with the Women's National Basketball Association that will see it stream games live on Prime Video.
The "Quality and GMP Compliance for Virtual Companies (Pharmaceutical and Biologics Industries)" conference has been added to ResearchAndMarkets.com's offering.
Former cruiserweight and heavyweight champion speaks to The Independent about his experiences with online abuse and how it must be tackled
The UK's competition watchdog has warned package holiday companies to respect the refund rights of holidaymakers as the return of leisure travel approaches. The CMA today published an open letter "to remind firms of their legal obligations and the need to ensure refund options are clear and accessible" this summer, with travel still subject to restrictions and potential last minute changes. The body said it also sent the letter directly to 100 package holiday firms it has "received the most complaints about".
Inspired by her father's release from prison, St Vincent says her new album feels like a lifeline.
The Blairite reflex is to blame the left for every failure, but there are administrations around the country showing what a modern, socialist Labour Party can achieve
Perfect for advanced gum care, sensitive teeth and whitening, the likes of Oral B and Philips are pros when it comes to oral hygiene
Just 21% in favour of resolution by activist investors proposing tougher emissions targets
Dublin, May 13, 2021 (GLOBE NEWSWIRE) -- The "Naloxone Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029" report has been added to ResearchAndMarkets.com's offering. The global naloxone market held US$ 3,359.5 Mn in 2020 and expected to grow at compound annual growth rate (CAGR) of 9.7% during the forecast period from 2021 to 2029. Naloxone is an opioid antagonist designed to rapidly reverse opioid overdose. Naloxone is able to restore normal respiration of a person whose breathing has stopped or slowed down due to opioid or heroin overdose. Currently, opioid abuse is one of the foremost cause of drug overdose and leading cause of death globally. However, it is more common in North America and Europe. The problem is paramount in the United States, where the mortality due to opioid overdose surged by 21% in 2016. The opioid crises in the U.S. is has reached epidemic phase, causing serious healthcare costs and losses to resources. The excessive need for better treatment and people suffering from opioid dependence is resulting in the growth in naloxone market in the United States. Opioid dependence is a serious concern globally, with more than 25 million people affected. The problem exists in both developed as well as developing countries, but is greatest in the Unites States. Heroin is the most abused opioid in the world apart from U.S. where opioid prescription painkillers are the largely consumed leading to dependency and overdose. All these factors act as a drivers of the global naloxone market. However, overall the price of Naloxone is rising and acting as a barrier to reduce the number of deaths caused due to opioid overdose. In the United States the effect of sky rocketing prices is being reduced with supportive insurance plans and free sale of Naloxone through community based organizations or public health programs.Rising Awareness Related to Opioid Overdose and its Effective Treatment in Developed as well as Developing CountriesGovernment and non-government agencies across the developed and developing countries are introducing awareness campaigns to educate people about the overdose of Naloxone and treatment options. For example, Good Samaritan laws is established in the 40 states in the U.S. providing protection for people reporting overdoses in good faith. The scope of offenses are protected by immunity provision that differ state wise.North America Dominated the Global Naloxone MarketIn 2020, North America held the largest share in the global naloxone market owing wide presence of pharmaceutical giants, huge manufacturing base and favorable government initiative to curb opioid overdose crises in the region. U.S. is the leading market for Naloxone due to sharp increase in the prescription painkillers resulting in the over 10 million high-risk opioid users in the U.S. It is estimated that half this population have developed dependence and only 16% are undergoing treatment. Increasing government campaigns regarding knowledge and awareness of opioid dependence and risks have further driven the market for naloxone. Efficient reimbursement scenario and subsidized rate of the medication due to The Affordable Care Act has led to the heightened demand for naloxone. Europe emerged as the fastest growing region due to growing cases of opioid dependence, awareness and greater access to treatment.Historical & Forecast PeriodMarket is studied in order to understand the current dynamics and future trends in the global naloxone market. The study includes market size and forecast for all considered segments presented in the report for the period from 2021 to 2029, along with respective compound annual growth rate (CAGRs) for the forecast period from 2021 to 2029, considering 2017 as the base year. The key players currently engaged in naloxone market include Hospira (Pfizer, Inc.), Mylan N.V., Kaleo, Inc., Amphastar Pharmaceuticals, Inc., Adapt Pharma, Inc., Mundipharma International Limited among others.The market players are engaged in receiving marketing authorization in North America and Europe owing greater target population.In 2020, Mylan N.V. launched naloxone hydrochloride injection in the U.S.; while Mundipharma received European Medicines Approval (EMA) for intranasal naloxone in 2017.Number of generic manufacturers are operating in the market and account for a significant share in the naloxone market. Key Topics Covered: Chapter 1. PrefaceChapter 2. Executive Summary2.1. Global Naloxone Market PortraitureChapter 3. Global Naloxone: Market Dynamics and Outlook3.1. Overview3.2. Drivers3.3. Challenges3.4. Opportunities3.5. Attractive Investment Proposition, by Geography, 20203.6. Competitive LandscapeChapter 4. Global Naloxone Market, by Formulation, 2019 - 2029 (US$ Mn)4.1. Overview4.2. Parenteral4.2.1. Evzio4.2.2. Generic Drugs4.3. Intranasal4.3.1. NARCAN4.4. Sublingual4.4.1. Zubsolv4.4.2. Suboxone4.4.3. Generic DrugsChapter 5. Global Naloxone Market, by Dosage, 2019 - 2029 (US$ Mn)5.1. Overview5.2. 4mg/0.1 ml5.3. 2mg/0.1 ml5.4. 0.4 mg/0.4 ml5.5. 2mg/0.4 ml5.6. Others (1mg/ml, 0.4 mg/ml, 4mg/10ml)Chapter 6. Global Naloxone Market, by Sales Channel, 2019 - 2029 (US$ Mn)6.1. Overview6.2. Hospitals Pharmacy6.3. Outpatient Retail Pharmacy6.4. Online Pharmacy6.5. WholesalerChapter 7. Global Naloxone Market, by Geography, 2019 - 2029 (US$ Mn)7.1. OverviewChapter 8. Profiles8.1. Mylan N.V.8.2. Indivior Plc.8.3. Sandoz (Novartis AG)8.4. Adapt Pharma, Inc.8.5. Amphastar Pharmaceuticals, Inc.8.6. INSYS Therapeutics, Inc.8.7. Mundipharma International Limited8.8. Kaleo, Inc.8.9. Orexo AB8.10. Kern Pharma, S.L.8.11. Hospira (Pfizer, Inc.)8.12. UCB Pharma For more information about this report visit https://www.researchandmarkets.com/r/uud69i CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900